[HTML] nih.gov

[HTML][HTML] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread

E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
被引用次数：106 相关文章

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread

E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - hero.epa.gov
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread

E Giannoni, ML Taddei, A Morandi, G Comito… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
[PDF] semanticscholar.org

[PDF][PDF] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread

E Giannoni, ML Taddei, A Morandi, G Comito… - pdfs.semanticscholar.org
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
[PDF] psu.edu

[PDF][PDF] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread

E Giannoni, ML Taddei, A Morandi, G Comito… - Citeseer
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.

E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - europepmc.org
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
[HTML] oncotarget.com

[HTML][HTML] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread

E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - oncotarget.com
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and
prostate cancer metastatic spread | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget …

[引用][C] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread

E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - cir.nii.ac.jp
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and
prostate cancer metastatic spread | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread

E Giannoni, ML Taddei, A Morandi, G Comito… - ONCOTARGET, 2015 - flore.unifi.it
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.

E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - europepmc.org
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …